» Articles » PMID: 33008107

Glucose, Fructose, and Urate Transporters in the Choroid Plexus Epithelium

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Oct 3
PMID 33008107
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The choroid plexus plays a central role in the regulation of the microenvironment of the central nervous system by secreting the majority of the cerebrospinal fluid and controlling its composition, despite that it only represents approximately 1% of the total brain weight. In addition to a variety of transporter and channel proteins for solutes and water, the choroid plexus epithelial cells are equipped with glucose, fructose, and urate transporters that are used as energy sources or antioxidative neuroprotective substrates. This review focuses on the recent advances in the understanding of the transporters of the SLC2A and SLC5A families (GLUT1, SGLT2, GLUT5, GLUT8, and GLUT9), as well as on the urate-transporting URAT1 and BCRP/ABCG2, which are expressed in choroid plexus epithelial cells. The glucose, fructose, and urate transporters repertoire in the choroid plexus epithelium share similar features with the renal proximal tubular epithelium, although some of these transporters exhibit inversely polarized submembrane localization. Since choroid plexus epithelial cells have high energy demands for proper functioning, a decline in the expression and function of these transporters can contribute to the process of age-associated brain impairment and pathophysiology of neurodegenerative diseases.

Citing Articles

A New Perspective on the Prediction and Treatment of Stroke: The Role of Uric Acid.

Zhu B, Huang X, Zhang J, Wang X, Tian S, Zhan T Neurosci Bull. 2024; 41(3):486-500.

PMID: 39312108 PMC: 11876515. DOI: 10.1007/s12264-024-01301-3.


Uric acid and alterations of purine recycling disorders in Parkinson's disease: a cross-sectional study.

Shima S, Mizutani Y, Yoshimoto J, Maeda Y, Ohdake R, Nagao R NPJ Parkinsons Dis. 2024; 10(1):170.

PMID: 39251680 PMC: 11385569. DOI: 10.1038/s41531-024-00785-0.


Glymphatic influx and clearance are perturbed in Huntington's disease.

Liu H, Chen L, Zhang C, Liu C, Li Y, Cheng L JCI Insight. 2024; 9(20).

PMID: 39226105 PMC: 11530125. DOI: 10.1172/jci.insight.172286.


Circadian ABCG2 Expression Influences the Brain Uptake of Donepezil across the Blood-Cerebrospinal Fluid Barrier.

Furtado A, Duarte A, Costa A, Goncalves I, Santos C, Gallardo E Int J Mol Sci. 2024; 25(9).

PMID: 38732233 PMC: 11084460. DOI: 10.3390/ijms25095014.


Transporters, Ion Channels, and Junctional Proteins in Choroid Plexus Epithelial Cells.

Ueno M, Chiba Y, Murakami R, Miyai Y, Matsumoto K, Wakamatsu K Biomedicines. 2024; 12(4).

PMID: 38672064 PMC: 11048166. DOI: 10.3390/biomedicines12040708.


References
1.
Li J, Badve S, Zhou Z, Rodgers A, Day R, Oh R . The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program. Lancet Rheumatol. 2024; 1(4):e220-e228. DOI: 10.1016/S2665-9913(19)30078-5. View

2.
Morris M, Rodriguez-Cruz V, Felmlee M . SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers. AAPS J. 2017; 19(5):1317-1331. PMC: 6467070. DOI: 10.1208/s12248-017-0110-8. View

3.
Navale A, Paranjape A . Glucose transporters: physiological and pathological roles. Biophys Rev. 2017; 8(1):5-9. PMC: 5425736. DOI: 10.1007/s12551-015-0186-2. View

4.
. 9. Pharmacologic Approaches to Glycemic Treatment: . Diabetes Care. 2018; 42(Suppl 1):S90-S102. DOI: 10.2337/dc19-S009. View

5.
Spector R, Johanson C . Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy. Pharm Res. 2006; 23(11):2515-24. DOI: 10.1007/s11095-006-9091-5. View